--2025/Q2-- / 419.800M--
--2024/Q4-- / 390.800M--
--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 15.600
- -0.860-5.22%
Close Dec 27 16:00 ET
- 15.600
- 0.0000.00%
Post 20:01 ET
5.22BMarket Cap179.31P/E (TTM)
16.400High15.365Low3.85KVolume16.400Open16.460Pre Close61.63KTurnover0.02%Turnover Ratio1733.33P/E (Static)334.72MShares19.99052wk High21.82P/B265.20MFloat Cap14.44052wk Low--Dividend TTM17.00MShs Float19.990Historical High--Div YieldTTM6.29%Amplitude14.440Historical Low16.020Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Heat List
US
Overall
Symbol
Price
% Chg
No Data
